Self-expandable metal stent placement for recurrent cancer in a surgically-altered stomach
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Gastric cancer is one of the most common malignancies and most frequent causes of cancer-related death worldwide. Radical surgical resection accomplished by total or distal gastrectomy represents the mainstay of curative treatment for gastric cancer; however, recurrent cancer still occurs in a significant amount of cases. Patients with recurrent cancer are generally incurable and often experience debilitating symptoms, such as nausea, vomiting, dysphagia, dehydration, and malnutrition, because of malignant gastric-outlet, duodenal, and jejunal obstructions. Consequently, such patients experience progressive deterioration of quality of life. If bypass surgery has not already been performed, it is not usually appropriated in the context of recurrent cancer and is associated with a high risk of morbidity and mortality. Endoscopic or fluoroscopic self-expandable metal stent placement represents an effective and safe method for palliative treatment of recurrent cancer in patients with the surgically-altered stomach. Therefore, it should be considered as the first-line option. Importantly, accurate knowledge of the surgically-altered anatomy and stricture location are critical to achieve successful treatment outcomes.
Abstract
Gastric cancer is one of the most common malignancies and most frequent causes of cancer-related death worldwide. Radical surgical resection accomplished by total or distal gastrectomy represents the mainstay of curative treatment for gastric cancer; however, recurrent cancer still occurs in a significant amount of cases. Patients with recurrent cancer are generally incurable and often experience debilitating symptoms, such as nausea, vomiting, dysphagia, dehydration, and malnutrition, because of malignant gastric-outlet, duodenal, and jejunal obstructions. Consequently, such patients experience progressive deterioration of quality of life. If bypass surgery has not already been performed, it is not usually appropriated in the context of recurrent cancer and is associated with a high risk of morbidity and mortality. Endoscopic or fluoroscopic self-expandable metal stent placement represents an effective and safe method for palliative treatment of recurrent cancer in patients with the surgically-altered stomach. Therefore, it should be considered as the first-line option. Importantly, accurate knowledge of the surgically-altered anatomy and stricture location are critical to achieve successful treatment outcomes.
참고문헌 (48)
- Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- Marrelli D, "Prediction of recurrence after radical surgery for gastric cancer : a scoring system obtained from a prospective multicenter study", Ann Surg, 241, pp.247~255 (2005)
- Yoo CH, "Recurrence following curative resection for gastric carcinoma", Br J Surg, 87, pp.236~242 (2000)
- Iwanaga T, "Mechanisms of late recurrence after radical surgery for gastric carcinoma", Am J Surg, 135, pp.637~640 (1978)
- Shchepotin I, "Radical treatment of locally recurrent gastric cancer", Am Surg, 61, pp.371~376 (1995)
- Lopera JE, "Gastroduodenal stent placement : current status", Radiographics, 24, pp.1561~1573 (2004)
- Jeurnink SM, "Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction : a comparison in 95 patients", J Surg Oncol, 96, pp.389~396 (2007)
- Jeurnink SM, "Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction(SUSTENT study) : a multicenter randomized trial", Gastrointest Endosc, 71, pp.490~499 (2010)
- No JH, "Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status : endoscopic stenting versus surgery", Gastrointest Endosc, 78, pp.55~62 (2013)
- Park CH, "Impact of carcinomatosis and ascites status on long-term outcomes of palliative treatment for patients with gastric outlet obstruction caused by unresectable gastric cancer : stent placement versus palliative gastrojejunostomy", Gastrointest Endosc, 81, pp.321~332 (2015)
- Thrumurthy SG, "The diagnosis and management of gastric cancer", BMJ, 347, pp.f6367~ (2013)
- Buhl K, "Quality of life and functional results following different types of resection for gastric carcinoma", Eur J Surg Oncol, 16, pp.404~409 (1990)
- Chin AC, "Total gastrectomy : options for the restoration of gastrointestinal continuity", Lancet Oncol, 4, pp.271~276 (2003)
- Stange DE, "Gastric Cancer", pp.175~183 (2015), Springer
- Varadarajulu S, "Enteral stents", Gastrointest Endosc, 74, pp.455~464 (2011)
- Kochar R, "Enteral stents : from esophagus to colon", Gastrointest Endosc, 78, pp.913~918 (2013)
- Kim JH, "Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions : prospective evaluation of results and factors influencing outcome in 213 patients", Gastrointest Endosc, 66, pp.256~264 (2007)
- Oh D, "Efficacy and safety of a partially covered duodenal stent for malignant gastroduodenal obstruction: a pilot study", Gastrointest Endosc, 82, pp.32~36 (2015)
- Isayama H, "Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent", Gastrointest Endosc, 75, pp.757~763 (2012)
- Lee H, "Covered metallic stents with an anti-migration design vs. uncovered stents for the palliation of malignant gastric outlet obstruction: a multicenter, randomized trial", Am J Gastroenterol, 110, pp.1440~1449 (2015)
- Baron TH, "Enteral self-expandable stents", Gastrointest Endosc, 58, pp.421~433 (2003)
- Maetani I, "Self-expandable metallic stent placement for palliation in gastric outlet obstruction", Ann Palliat Med, 3, pp.54~64 (2014)
- Song HY, "Use of a newly designed multifunctional coil catheter for stent placement in the upper gastrointestinal tract", J Vasc Interv Radiol, 15, pp.369~373 (2004)
- Katsanos K, "Stenting of the upper gastrointestinal tract : current status", Cardiovasc Intervent Radiol, 33, pp.690~705 (2010)
- Park JH, "Usefulness of a guiding sheath for fluoroscopic stent placement in patients with malignant gastroduodenal obstruction", Acta Radiol, 54, pp.267~271 (2013)
- Song HY, "Metallic stent placement in patients with recurrent cancer after gastrojejunostomy", J Vasc Interv Radiol, 18, pp.1538~1546 (2007)
- Soo I, "Palliation of malignant gastric outlet obstruction with simultaneous endoscopic insertion of afferent and efferent jejunal limb enteral stents in patients with recurrent malignancy", Surg Endosc, 30, pp.521~525 (2016)
- Han K, "Afferent loop syndrome: treatment by means of the placement of dual stents", AJR Am J Roentgenol, pp.W761~W766 (2012)
- Chevallier P, "Percutaneous jejunostomy and stent placement for treatment of malignant Rouxen-Y obstruction : a case report", Clin Imaging, 30, pp.283~286 (2006)
- Laasch HU, "Obstructive jaundice after bilioenteric anastomosis: transhepatic and direct percutaneous enteral stent insertion for afferent loop occlusion", Gut Liver, 4(Suppl 1), pp.S89~S95 (2010)
- Mendelsohn RB, "Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction", Gastrointest Endosc, 73, pp.1135~1140 (2011)
- Jeon HH, "Carcniomatosis matters : clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction", Surg Endosc, 28, pp.988~995 (2014)
- Chen CY, "The impact of chronic hepatitis B viral infection on gastrointestinal motility", Eur J Gastroenterol Hepatol, 12, pp.995~1000 (2000)
- Aqel BA, "Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites", Clin Gastroenterol Hepatol, 3, pp.1095~1100 (2005)
- Park KB, "Malignant obstruction of gastric outlet and duodenum : palliation with flexible covered metallic stents", Radiology, 219, pp.679~683 (2001)
- Jeong JY, "Palliation of anastomotic obstructions in recurrent gastric carcinoma with the use of covered metallic stents : clinical results in 25 patients", Surgery, 135, pp.171~177 (2004)
- Kim JH, "Anastomotic recurrence of gastric cancer after total gastrectomy with esophagojejunostomy : palliation with covered expandable metallic stents", J Vasc Interv Radiol, 18, pp.964~969 (2007)
- Yang ZQ, "Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction", J Vasc Interv Radiol, 18, pp.1533~1537 (2007)
- Song GA, "Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery : uncovered versus simultaneously deployed uncovered and covered(double)self-expandable metal stents", Gastrointest Endosc, 65, pp.782~787 (2007)
- Cho YK, "Clinical outcomes of self-expandable metal stents in palliation of malignant anastomotic strictures caused by recurrent gastric cancer", World J Gastroenterol, 15, pp.3523~3527 (2009)
- Kim HJ, "Self-expandable metal stents for recurrent malignant obstruction after gastric surgery", Hepatogastroenterology, 56, pp.914~917 (2009)
- Kim J, "Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer", Surg Endosc, 25, pp.1505~1513 (2011)
- Park JH, "Placement of a covered expandable metallic stent to treat nonanastomotic malignant jejunal obstructions after total gastrectomy with esophagojejunostomy", AJR Am J Roentgenol, 198, pp.1203~1207 (2012)
- Park JH, "Metallic stent placement in patients with recurrent malignant obstruction in the surgically altered stomach", Ann Surg Oncol, 21, pp.2036~2043 (2014)
- Zhu HD, "Conventional stents versus stents loaded with(125)iodine seeds for the treatment of unresectable oesophageal cancer : a multicentre, randomised phase 3 trial", Lancet Oncol, 15, pp.612~619 (2014)
- Moon S, "An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis", Biomaterials, 32, pp.3603~3610 (2011)
- Kim SY, "Paclitaxel-eluting nanofiber-covered self-expanding nonvascular stent for palliative chemotherapy of gastrointestinal cancer and its related stenosis", Biomed Microdevices, 16, pp.897~904 (2014)
- Lei L, "5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application : drug release, microstructure, and ex vivo permeation behaviors", J Control Release, 146, pp.45~53 (2010)